344
Participants
Start Date
November 9, 2017
Primary Completion Date
July 10, 2020
Study Completion Date
July 10, 2020
LY3154207
Administered orally.
Placebo
Administered orally.
NYU Langone, New York
Parker Jewish Insititue for Heatlh Care and Rehabilition, New Hyde Park
Adirondack Medical Research, Glens Falls
Alzheimer's Disease and Memory Disorders Center, Buffalo
Dent Neurological Institute, Amherst
Penn State Univ. Milton S. Hershey Medical Center, Hershey
Abington Neurological Associates, Willow Grove
Pennsylvania Hospital, Philadelphia
Thomas Jefferson University, Philadelphia
Christiana Care Health Service, Newark
Georgetown University Hospital, Washington D.C.
Sentara Neurology Specialists, Virginia Beach
Wake Forest University Health Sciences, Winston-Salem
Carolinas Healthcare System, Charlotte
Medical University of South Carolina, Charleston
Emory University, Atlanta
Atlanta Center of Medical Research, Atlanta
Neurology Associates of Ormond Beach, Ormond Beach
Norman Fixel Institute for Neurological Diseases (FIND), Gainesville
ClinCloud, LLC, Maitland
Compass Research, Orlando
Visionary Investigators Network -VIN-Margarita Almeida, Pembroke Pines
Visionary Investigators Network, Miami
Suncoast Research Group, LLC, Miami
VIN - Victor Faradji, Miami
Visionary Investigators Network, Aventura
JEM Research Institute, Atlantis
Parkinson's Disease and Movement Disorders, Boca Raton
Axiom Research, Tampa
Collier Neurologic Specialists, Naples
Renstar Medical Research, Ocala
University of Alabama Birmingham, Birmingham
Indiana University School of Medicine, Indianapolis
Josephson Wallack Munshower Neurology, Indianapolis
University of Michigan, Ann Arbor
QUEST Research Institute, Farmington Hills
University of Wisconsin-Madison Hospital and Health Clinic, Madison
Central DuPage Hospital, Winfield
Clinical Research Professionals, Chesterfield
Washington University School of Medicine, St Louis
University of Kansas School of Medicine, Kansas City
Texas Neurology, PA, Dallas
Neurology Consultants of Dallas, PA, Dallas
Baylor College of Medicine, Houston
Houston Methodist Research Ins, Houston
University of Colorado Hospital, Aurora
Rocky Mountain Movement Disorders Center, Englewood
Denver Neurological Research, Denver
Barrow Neurological Institute, Phoenix
Mayo Clinic of Scottsdale, Scottsdale
Banner Sun Health Research Institute, Sun City
University of Arizona Health Sciences, Tucson
Cleveland Clinic of Las Vegas, Las Vegas
University of Southern California School of Medicine, Los Angeles
Collaborative Neuroscience Network - CNS, Long Beach
SC3 Research Group Inc Pasadena, Pasadena
SC3 Research Group Inc Reseda, Reseda
University of CA, Irvine, Irvine
Parkinson'S & Movement Disorder Institute, Fountain Valley
Pacific Neuroscience Medical Group, Oxnard
Stanford Neuroscience Health Center, Palo Alto
University of California, Davis - Health Systems, Sacramento
Evergreen Professional Plaza, Kirkland
New England Institute for Clinical Research, Stamford
Hartford Healthcare Chase Movement Disorders Center, Vernon
Maine Neurology, Scarborough
New England Neurological Associates, PC, Methuen
Dartmouth Hitchcock Medical Center, Lebanon
The Cognitive and Research Center of NJ, Springfield
Bio Behavioral Health, Toms River
Northwest Clinical Research Center, Bellevue
Toronto Memory Program, Toronto
Ottawa Hospital Research Institute, Ottawa
Cortex, PSC, Las Piedras
Instituto de Neurologia Dra. Ivonne Fraga, San Juan
University of Puerto Rico, San Juan
Santa Cruz Behavioral PSC, Bayamón
Eli Lilly and Company
INDUSTRY